Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons

Background. Antiretroviral preexposure prophylaxis (PrEP), using daily oral combination tenofovir disoproxil fumarate plus emtricitabine, is an effective human immunodeficiency virus (HIV) prevention strategy for populations at high risk of HIV acquisition. Although the primary mode of action for th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Infect Dis
Päätekijät: Pattacini, Laura, Murnane, Pamela M., Baeten, Jared M., Fluharty, Tayler R., Thomas, Katherine K., Bukusi, Elizabeth, Katabira, Elly, Mugo, Nelly, Donnell, Deborah, Lingappa, Jairam R., Celum, Connie, Marzinke, Mark, McElrath, M. Juliana, Lund, Jennifer M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2015
Aiheet:
Major Articles and Brief Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4836720/
https://ncbi.nlm.nih.gov/pubmed/25520426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu815
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia